FDA applicant

Nymox Pharmaceutical Corporation

Maywood, NJ1 decision2002–20020 recalls

FDA records 1 decision for Nymox Pharmaceutical Corporation (Maywood, NJ) in 2002: 1 510(k) clearance. All are in product code MRS (Test System, Nicotine, Cotinine, Metabolites). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Nymox Pharmaceutical Corporation’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Nymox Pharmaceutical Corporation since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Nymox Pharmaceutical Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Nymox Pharmaceutical Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Nymox Pharmaceutical Corporation

Which product codes does it file in?

What has FDA decided for it lately?